Table 1_Associations of apolipoprotein A1, apolipoprotein B, and their ratio with novel cardiometabolic indices in adults with coronary artery disease.doc

However, their associations with novel cardiometabolic indices [triglyceride glucose body mass index (TyG-BMI), atherogenic index of plasma (AIP), and atherogenic index (AI)] remain scarce in CAD patients.</p>Methods<p>A total of 11,934 patients with CAD (average age: 61.7 years) were included in this hospital-based cross-sectional study.

TyG-BMI, AIP, and AI were calculated using the following formulas: TyG index = Ln[FBG (mg/dL) × triglyceride (mg/dL)/2], Log[triglyceride (mg/dL)/high-density lipoprotein cholesterol (HDL-C, mg/dL)], and non-HDL-C (mg/dL)/HDL-C (mg/dL).</p>Results<p>Overall, serum ApoA1 was inversely associated with TyG-BMI, AIP, and AI, while ApoB and the ApoB/A1 ratio exhibited positive associations with TyG-BMI, AIP, and AI. In multivariable analysis, ApoA1 was inversely associated with cardiometabolic indices [TyG-BMI_{Q(quartile)4 vs. Q1}: 225.800 vs. 228.217, AIP_{Q4 vs. Q1}: 0.356 vs. 0.478, AI_{Q4 vs. Q1}: 1.928 vs. 2.525].